www.oncozine.com
Open in
urlscan Pro
35.190.31.54
Public Scan
Submitted URL: http://www.oncozine.com/
Effective URL: https://www.oncozine.com/
Submission: On November 04 via manual from US — Scanned from DE
Effective URL: https://www.oncozine.com/
Submission: On November 04 via manual from US — Scanned from DE
Form analysis 4 forms found in the DOM
GET https://www.oncozine.com/
<form method="get" class="td-search-form" action="https://www.oncozine.com/"> <!-- close button -->
<div class="td-search-close"> <span><i class="td-icon-close-mobile"></i></span></div>
<div role="search" class="td-search-input"> <span>Search</span> <input id="td-header-search-mob" type="text" value="" name="s" autocomplete="off"></div>
</form>POST #
<form id="loginForm" action="#" method="post">
<div class="td-login-inputs"><input class="td-login-input" autocomplete="username" type="text" name="login_email" id="login_email" value="" required=""><label for="login_email">your username</label></div>
<div class="td-login-inputs"><input class="td-login-input" autocomplete="current-password" type="password" name="login_pass" id="login_pass" value="" required=""><label for="login_pass">your password</label></div> <input type="button"
name="login_button" id="login_button" class="wpb_button btn td-login-button" value="Login">
</form>POST #
<form id="forgotpassForm" action="#" method="post">
<div class="td-login-inputs"><input class="td-login-input" type="text" name="forgot_email" id="forgot_email" value="" required=""><label for="forgot_email">your email</label></div> <input type="button" name="forgot_button" id="forgot_button"
class="wpb_button btn td-login-button" value="Send My Password">
</form>GET https://www.oncozine.com/
<form method="get" class="td-search-form" action="https://www.oncozine.com/">
<div role="search" class="td-head-form-search-wrap"> <input id="td-header-search" type="text" value="" name="s" autocomplete="off"><input class="wpb_button wpb_btn-inverse btn" type="submit" id="td-header-search-top" value="Search"></div>
</form>Text Content
* Home
* Advertisement & Sponsorship Options
* Download Our Media Kit
* Changing Physician Behavior
* Cancer A – Z
* Drug Developmemt Technologies
* A Novel Technology based on Somatic Hypermutation (SHM)
* Editorial Advisory Board
* Join Our Editorial Advisory Board
* Contact Us
* Terms and Conditions
* Publications
* ADC Review | J. Antibody-drug Conjugates
* Resources for For Clinicians
* Drug Map (ADC)
* Peer Review Articles
* The Review
* Changing Strategies in the War on Cancer
* Changing Strategies in the War on Cancer – Episode 1
* Changing Strategies in the War on Cancer – Episode 2
* Changing Strategies in the War on Cancer – Episode 3
* Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
* Journal of CAR T-Cell Therapy
* About CAR T-cells
* Frequently Asked Questions
* Types of Articles
* Submit a Manuscript
* The Onco’Zine Brief
* The Network
* The Episodes
* How to Support The Onco’Zine Brief
* Corporate Underwriting and Sponsorship
* The Onco’Zine Dossier
* Thalidomide: A History
* Thalidomide: In the Shadow of Death
* Controversy: The involvement of Ciba AG in the development of
Thalidomide
* Thalidomide’s Secret Past: The Link with Nazi Germany
* Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in
the ‘War’ Against Cancer
* Smoking and Health
* New Surgeon General’s Report Presents the Unfiltered Truth About
Tobacco
* Smoking and the Lost Legacy of the First Surgeon General’s Report on
Smoking and Health
* Tobacco Control in the United States Has Saved 8 Million Lives In Last
50 Years
* Tobacco Companies are Finally Moving Closer to Revealing the Truth
about Smoking
* The Harmful Effects of Smoking: The Public Denial in the Early-mid
1960s
* Drug Approvals 2017 – 2020
* Oncology & Hematology – FDA Drug Approvals 2018
* Oncology & Hematology – FDA Drug Approvals 2019
* Oncology & Hematology – FDA Drug Approvals 2020
* Articles
* Latest Articles
* Expert Interviews
* Editorials and Commentaries
* Eric Rosenthal Reports
* Publications
* News
* Business & Economics
* Clinical Development
* Conference Coverage
* The Onco’Zine Brief
* The Episodes
* National Advertising
* Resources
* Membership
* Agenda
* Join Today
* Video
* Careers
Search
* About
* Advertise
* Advisory Board
* Contact Us
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
ONCO'ZINE
Advertisement #1
* Home
* Advertisement & Sponsorship Options
* Download Our Media Kit
* Changing Physician Behavior
* Cancer A – Z
* Drug Developmemt Technologies
* A Novel Technology based on Somatic Hypermutation (SHM)
* Editorial Advisory Board
* Join Our Editorial Advisory Board
* Contact Us
* Terms and Conditions
* Publications
* ADC Review | J. Antibody-drug Conjugates
* Resources for For Clinicians
* Drug Map (ADC)
* Peer Review Articles
* The Review
* Changing Strategies in the War on Cancer
* Changing Strategies in the War on Cancer – Episode 1
* Changing Strategies in the War on Cancer – Episode 2
* Changing Strategies in the War on Cancer – Episode 3
* Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
* Journal of CAR T-Cell Therapy
* About CAR T-cells
* Frequently Asked Questions
* Types of Articles
* Submit a Manuscript
* The Onco’Zine Brief
* The Network
* The Episodes
* How to Support The Onco’Zine Brief
* Corporate Underwriting and Sponsorship
* The Onco’Zine Dossier
* Thalidomide: A History
* Thalidomide: In the Shadow of Death
* Controversy: The involvement of Ciba AG in the development of
Thalidomide
* Thalidomide’s Secret Past: The Link with Nazi Germany
* Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in
the ‘War’ Against Cancer
* Smoking and Health
* New Surgeon General’s Report Presents the Unfiltered Truth About
Tobacco
* Smoking and the Lost Legacy of the First Surgeon General’s Report on
Smoking and Health
* Tobacco Control in the United States Has Saved 8 Million Lives In Last
50 Years
* Tobacco Companies are Finally Moving Closer to Revealing the Truth
about Smoking
* The Harmful Effects of Smoking: The Public Denial in the Early-mid
1960s
* Drug Approvals 2017 – 2020
* Oncology & Hematology – FDA Drug Approvals 2018
* Oncology & Hematology – FDA Drug Approvals 2019
* Oncology & Hematology – FDA Drug Approvals 2020
* Articles
* Latest Articles
* Expert Interviews
* Editorials and Commentaries
* Eric Rosenthal Reports
* Publications
* News
* Business & Economics
* Clinical Development
* Conference Coverage
* The Onco’Zine Brief
* The Episodes
* National Advertising
* Resources
* Membership
* Agenda
* Join Today
* Video
* Careers
GROWING NUMBER OF STUDIES INVESTIGATE NEW TREATMENT OPTIONS FOR OF PANCREATIC
DUCTAL ADENOCARCINOMA
Editorial Team - October 25, 2023
ESMO 2023: LONG-TERM STUDY INVESTIGATING BREAST CANCER RISK LINKED TO AIR
POLLUTION IN EUROPE
THOR-2 STUDY: IMPROVED RATES OF RECURRENCE-FREE SURVIVAL IN HIGH-RISK
NON-MUSCLE-INVASIVE BC
COMBINATION OF ADAGRASIB AND PEMBROLIZUMAB IN FIRST-LINE NON-SMALL CELL LUNG
CANCER (NSCLC))Y
UPDATED CLINICAL PHASE 1 DATA OF GIVASTOMIG SHOWS BENEFIT IN TREATMENT GASTRIC
CANCER
FEATURED
THINK GLOBALLY, ACT GLOBALLY: THE KEY ROLE GLOBAL HUBS PLAY IN ONCOLOGICAL DRUG
DEVELOPMENT
Joe Woolery, B.S., Pharm.D., BCOP - October 3, 2023
THE INTERCONNECTEDNESS OF LONELINESS AND DEPRESSION ON OLDER INDIVIDUALS
DIAGNOSED WITH CANCER
Emily Carlucci - October 2, 2023
OCTOBER BREAST CANCER AWARENESS MONTH: EMPHASIZING EQUITY IN ACCESS TO EARLY
DETECTION
Danielle Garcia - September 20, 2023
BREAKING BARRIERS TO ACCESS: EMPOWERING VULNERABLE POPULATIONS WITH CELL AND
GENE THERAPY
Jennifer Klarer - September 18, 2023
RECRUITING AND RETAINING NURSES: A CRITICAL CHALLENGE FACING THE HEALTHCARE
INDUSTRY
Hilton M. Hudson, MD - September 11, 2023
EMBRACING FAIR DATA ON THE PATH TO AI-READINESS
Christian Olsen - August 29, 2023
ARE PRICE CONTROLS DISRUPTING CLINICAL TRIALS AND STIFLING MEDICAL INNOVATION?
Harsha Karur Rajasimha, MS, Ph.D - August 15, 2023
WHAT ARE THE BENEFITS OF A BLOOD TEST THAT SCREENS ‘HEALTHY PEOPLE’ FOR CANCER?
Mark Kreidler - August 11, 2023
Advertisement
NEWS
GROWING NUMBER OF STUDIES INVESTIGATE NEW TREATMENT OPTIONS FOR OF PANCREATIC
DUCTAL ADENOCARCINOMA
Editorial Team - October 25, 2023
ESMO 2023: LONG-TERM STUDY INVESTIGATING BREAST CANCER RISK LINKED TO AIR
POLLUTION IN EUROPE
Peter Hofland - October 24, 2023
THOR-2 STUDY: IMPROVED RATES OF RECURRENCE-FREE SURVIVAL IN HIGH-RISK
NON-MUSCLE-INVASIVE BC
Danielle Garcia - October 23, 2023
COMBINATION OF ADAGRASIB AND PEMBROLIZUMAB IN FIRST-LINE NON-SMALL CELL LUNG
CANCER (NSCLC))Y
Editorial Team - October 22, 2023
UPDATED CLINICAL PHASE 1 DATA OF GIVASTOMIG SHOWS BENEFIT IN TREATMENT GASTRIC
CANCER
Editorial Team - October 22, 2023
ESMO 2023: CHANGES IN THE TREATMENT OF LUNG CANCER TREATMENT
Peter Hofland - October 19, 2023
ESMO 2023: CHANGING THE TREATMENT LANDSCAPE FOR GYNECOLOGICAL CANCERS
Peter Hofland - October 18, 2023
ESMO 2023: NOVEL TREATMENT OPTIONS DEMONSTRATE A GROWING IMPACT IN SOLID TUMOR
RESEARCH
Peter Hofland - October 17, 2023
STUDY SHOWS HOW MUTATIONS IN BRCA1 AFFECT CANCER SUSCEPTIBILITY IN WOMEN
Danielle Garcia - October 7, 2023
CHILDREN OF TEEN AND YOUNG ADULT WOMEN WITH A CANCER HISTORY ARE MORE LIKELY...
Danielle Garcia - October 7, 2023
RESEARCH BREAKTHROUGH SPARKS HOPE FOR PATIENTS DIAGNOSED WITH COLORECTAL CANCER
Danielle Garcia - October 7, 2023
SONALASENSE: DEVELOPING A SAFE AND EFFECTIVE NONINVASIVE TREATMENT FOR CANCER
Danielle Garcia - October 6, 2023
CONFERENCE COVERAGE
GROWING NUMBER OF STUDIES INVESTIGATE NEW TREATMENT OPTIONS FOR OF PANCREATIC
DUCTAL ADENOCARCINOMA
Editorial Team - October 25, 2023
ESMO 2023: LONG-TERM STUDY INVESTIGATING BREAST CANCER RISK LINKED TO AIR
POLLUTION IN EUROPE
Peter Hofland - October 24, 2023
THOR-2 STUDY: IMPROVED RATES OF RECURRENCE-FREE SURVIVAL IN HIGH-RISK
NON-MUSCLE-INVASIVE BC
Danielle Garcia - October 23, 2023
COMBINATION OF ADAGRASIB AND PEMBROLIZUMAB IN FIRST-LINE NON-SMALL CELL LUNG
CANCER (NSCLC))Y
Editorial Team - October 22, 2023
UPDATED CLINICAL PHASE 1 DATA OF GIVASTOMIG SHOWS BENEFIT IN TREATMENT GASTRIC
CANCER
Editorial Team - October 22, 2023
ESMO 2023: CHANGES IN THE TREATMENT OF LUNG CANCER TREATMENT
Peter Hofland - October 19, 2023
ESMO 2023: CHANGING THE TREATMENT LANDSCAPE FOR GYNECOLOGICAL CANCERS
Peter Hofland - October 18, 2023
LONG-TERM OUTCOMES OF RADIATION TECHNIQUES FOR THE TREATMENT OF LOCALLY ADVANCED
NSCLC
Peter Hofland - September 12, 2023
BRENTUXIMAB VEDOTIN + IMMUNOTHERAPY SHOWS 98% ORR AND 93% CR IN PATIENTS WITH
EARLY-STAGE...
Editorial Team - June 13, 2023
REDUCING RELIANCE ON BLOOD TRANSFUSIONS FOR PEOPLE WITH LOWER-RISK
MYELODYSPLASTIC SYNDROMES
Editorial Team - June 8, 2023
RADIATION AFTER CHEMOIMMUNOTHERAPY FOR PRIMARY MEDIASTINAL B-CELL LYMPHOMA MAY
NOT BE NECESSARY
Editorial Team - June 6, 2023
CILTACABTAGENE AUTOLEUCEL REDUCES RISK OF PROGRESSION OF MULTIPLE MYELOMA AFTER
LENALIDOMIDE
Editorial Team - June 5, 2023
Advertisement
EDITORIAL
SEVERE ORAL MUCOSITIS: COMPANIES PUT THEIR MONEY WHERE THE MOUTH IS AND VIE
FOR...
Bryan Oronsky, MD. Ph.D. - September 11, 2023
RECRUITING AND RETAINING NURSES: A CRITICAL CHALLENGE FACING THE HEALTHCARE
INDUSTRY
Hilton M. Hudson, MD - September 11, 2023
THE POWER OF CLINICALLY-DRIVEN TECHNOLOGY AND MEMBER-CENTRIC APPROACHES IN
CANCER CARE
Clarice Holmes, RN - August 2, 2023
WHY ARE PATIENT REGISTRIES KEY TO ACCELERATING RARE DISEASE RESEARCH?
Padma Rammoorthy, MD - July 28, 2023
SONODYNAMIC THERAPY: AN EMERGING TREATMENT FOR DEADLY BRAIN TUMORS
Ely Benaim, MD - July 25, 2023
A MULTICOMPONENT BIOMARKER APPROACH WILL SHIFT CANCER CARE
Ofer Sharon, MD, MBA - June 12, 2023
ERIC ROSENTHAL REPORTS
REMEMBERING EMIL “JAY” FREIREICH—THE MAN WHO MADE VINCE DEVITA A ‘BELIEVER’
Eric T. Rosenthal - February 13, 2021
WHY WERE TOP HHS OFFICIALS? INTERVIEWS THWARTED BY THEIR PRESS OFFICES?
Eric T. Rosenthal - March 5, 2019
EXPERT INTERVIEWS
SONALASENSE: DEVELOPING A SAFE AND EFFECTIVE NONINVASIVE TREATMENT FOR CANCER
Danielle Garcia - October 6, 2023
BE THE MATCH®: IMPROVING OUTCOMES AND PROVIDING HOPE TO PATIENTS IN NEED
Danielle Garcia - October 6, 2023
DEVELOPING A NEW STANDARD OF CARE: CANCER TREATMENT WITH PHOTOIMMUNOTHERAPY
Danielle Garcia - August 14, 2023
Advertisment #12
GROWING NUMBER OF STUDIES INVESTIGATE NEW TREATMENT OPTIONS FOR OF PANCREATIC
DUCTAL ADENOCARCINOMA
Editorial Team - October 25, 2023
ESMO 2023: LONG-TERM STUDY INVESTIGATING BREAST CANCER RISK LINKED TO AIR
POLLUTION IN EUROPE
Peter Hofland - October 24, 2023
THOR-2 STUDY: IMPROVED RATES OF RECURRENCE-FREE SURVIVAL IN HIGH-RISK
NON-MUSCLE-INVASIVE BC
Danielle Garcia - October 23, 2023
DAIICHI SANKYO OUT-LICENSES INVESTIGATIONAL AGENT DS-6051 TO ANHEART
THERAPEUTICS
Peter Hofland - December 19, 2018
HOW MEANINGFUL WILL CHANGES BE TO ETHICAL GUIDELINES FOLLOWING JOSE BASELGA’S
FALL?
Eric T. Rosenthal - October 9, 2018
REVERSAL OF FORTUNE: HOW A VILIFIED DRUG BECAME A LIFE-SAVING AGENT IN THE
‘WAR’...
Peter Hofland - November 30, 2013
* News2869
* Conference Coverage483
* Research & Development344
* Cancer Risk283
* Clinical Trial Updates268
* Clinical development239
* Business & Economics183
* Regulatory Updates119
* Op-Ed | Opinion103
* Editorials and Commentaries100
ABOUT US
Onco'Zine - The International Oncology Network, has been created to inform,
educate, and support physicians and healthcare professionals treating cancer
patients. The Journal reports on current research and development in oncology
and hematology and contains clinical information created specifically for
healthcare professionals.
FOLLOW US
* Home
* Advertisement & Sponsorship Options
* Download Our Media Kit
* Changing Physician Behavior
* Cancer A – Z
* Drug Developmemt Technologies
* A Novel Technology based on Somatic Hypermutation (SHM)
* Editorial Advisory Board
* Join Our Editorial Advisory Board
* Contact Us
* Terms and Conditions
* Publications
* ADC Review | J. Antibody-drug Conjugates
* Resources for For Clinicians
* Drug Map (ADC)
* Peer Review Articles
* The Review
* Changing Strategies in the War on Cancer
* Changing Strategies in the War on Cancer – Episode 1
* Changing Strategies in the War on Cancer – Episode 2
* Changing Strategies in the War on Cancer – Episode 3
* Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
* Journal of CAR T-Cell Therapy
* About CAR T-cells
* Frequently Asked Questions
* Types of Articles
* Submit a Manuscript
* The Onco’Zine Brief
* The Network
* The Episodes
* How to Support The Onco’Zine Brief
* Corporate Underwriting and Sponsorship
* The Onco’Zine Dossier
* Thalidomide: A History
* Thalidomide: In the Shadow of Death
* Controversy: The involvement of Ciba AG in the development of
Thalidomide
* Thalidomide’s Secret Past: The Link with Nazi Germany
* Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in
the ‘War’ Against Cancer
* Smoking and Health
* New Surgeon General’s Report Presents the Unfiltered Truth About
Tobacco
* Smoking and the Lost Legacy of the First Surgeon General’s Report on
Smoking and Health
* Tobacco Control in the United States Has Saved 8 Million Lives In Last
50 Years
* Tobacco Companies are Finally Moving Closer to Revealing the Truth
about Smoking
* The Harmful Effects of Smoking: The Public Denial in the Early-mid
1960s
* Drug Approvals 2017 – 2020
* Oncology & Hematology – FDA Drug Approvals 2018
* Oncology & Hematology – FDA Drug Approvals 2019
* Oncology & Hematology – FDA Drug Approvals 2020
* Articles
* Latest Articles
* Expert Interviews
* Editorials and Commentaries
* Eric Rosenthal Reports
* Publications
* News
* Business & Economics
* Clinical Development
* Conference Coverage
* The Onco’Zine Brief
* The Episodes
* National Advertising
* Resources
* Membership
* Agenda
* Join Today
* Video
* Careers
© 2001 - 2023 Sunvalley Communication, LLC. All Rights Reserved.
X